Pneumonia News and Research

Latest Pneumonia News and Research

Breakthrough discovery about Rhizobium radiobacter

A new discovery involving two Simon Fraser University scientists could lead to a little known and benign bacterium becoming a vital new tool in the development of a vaccine against human immunodeficiency virus.

29 Feb 2012

FDA clears Meridian Bioscience's TRU Legionella test

Meridian Bioscience, Inc. today announced that it has received FDA clearance from the U.S. Food and Drug Administration (FDA) for TRU Legionella, a new rapid assay for detection of legionellosis.

28 Feb 2012

USPTO issues two patents on 'Novel Shigella protein antigens and methods' to IVI

The International Vaccine Institute (IVI), an international organization based in Seoul devoted to research on the development and introduction of vaccines for the developing world, reached a milestone in its aim to prevent and control dysentery (also commonly called shigellosis or bloody diarrhea), a deadly disease that affects several million people worldwide.

27 Feb 2012

WHO urging Afghans to vaccinate children for measles following outbreak in western region

The WHO "is calling on all Afghans to vaccinate their children after a recent measles outbreak that has been made worse by severe weather that hampers access to immediate treatment as well as low immunization coverage," the U.N. News Centre reports.

24 Feb 2012

Pfizer responds to CDC’S ACIP discussion related to use of Prevnar 13 in adults over 50

Pfizer Inc. issued the following statement in response to today's discussion by the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) regarding the use of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine)in adults 50 years of age and older.

23 Feb 2012

Enrollment complete in Onyx Phase 3 ASPIRE trial for relapsed multiple myeloma

Onyx Pharmaceuticals, Inc. today announced that it has reached the target enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid) and low dose dexamethasone in patients with relapsed multiple myeloma.

23 Feb 2012

Intramuscular midazolam effective in treating status epilepticus

Drug delivery directly into muscle using an autoinjector is faster and may be more effective in stopping prolonged seizures, according to a study sponsored by the National Institutes of Health and conducted by a Wayne State University School of Medicine researcher.

17 Feb 2012

Compound makes imipenem 16 times more effective against antibiotic-resistant K. pneumoniae

North Carolina State University chemists have created a compound that makes existing antibiotics 16 times more effective against recently discovered antibiotic-resistant "superbugs."

14 Feb 2012

Grand Challenges Canada, Gates Foundation announce grants for innovative Global Health projects

"Grand Challenges Canada on Thursday announced 15 grants valued in total at more than $1.5 million awarded to some of Canada's most creative innovators from across the country in support of their work to improve global health conditions," according to a press release from the Sandra Rotman Centre for Global Health, which hosts Grand Challenges.

13 Feb 2012

Grand Challenges Canada announces 15 grants to support rising stars in global health

Grand Challenges Canada today announced 15 grants valued in total at more than $1.5 million awarded to some of Canada's most creative innovators from across the country in support of their work to improve global health conditions.

10 Feb 2012

Asian bird flu update for Ferbruary 2012

Health workers in Nepal are to cull thousands of chickens following the discovery of the H5N1 strain of bird flu in the southeastern part of the Himalayan country.

6 Feb 2012

New MRSA ‘superbug’ worries experts

A deadly mutant bug could be spreading among the public warn experts. The deadly strain of Methicillin-Resistant Staphylococcus Aureus (MRSA) called USA300 passes easily through skin-to-skin contact. It can also survive on surfaces and so has the potential to be picked up on crowded buses and tubes. The first cases were seen in the US but cases are now being reported in the community and not just hospitals in Britain.

3 Feb 2012

Potential way to block second wave of death from pneumonia treatment

An international research team may have found a way to block a second wave of death that can result from pneumonia treatment.

1 Feb 2012

Certain strains of P. aeruginosa cause WBCs to produce high levels of histamine

Could some cases of asthma actually be caused by an allergic reaction to a common environmental bacteria? New research findings published in the Journal of Leukocyte Biology suggests that this idea may not be as far-fetched as it seems. In a research report appearing in the February 2012 print issue, researchers show a link between common environmental bacteria and airway inflammation.

1 Feb 2012

Study investigates how bacteria change their disguise to evade vaccines

Genetics has provided surprising insights into why vaccines used in both the UK and US to combat serious childhood infections can eventually fail. The study, published today in Nature Genetics, which investigates how bacteria change their disguise to evade the vaccines, has implications for how future vaccines can be made more effective.

30 Jan 2012

New study aims to prevent bacterial infections in sub-Saharan African kids

Bacteria infections - most of which are preventable via vaccines readily available in the developed world - and not malaria are the leading cause of death for children in sub-Saharan Africa. A new Michigan State University project based in Nigeria and funded by a $5.8 million grant aims to help prevent these diseases by collecting local data on the ailments, spurring vaccine use and development. Funded by the Bill & Melinda Gates Foundation, the research led by Stephen Obaro focuses on diseases such as pneumonia, sepsis and meningitis.

25 Jan 2012

EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC

MSD today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the use of REMICADE (infliximab) in the treatment of severely active ulcerative colitis (UC) in pediatric patients ages 6 to 17 years, who have had an inadequate response to conventional therapy, including corticosteroids and 6-mercaptopurine or azathioprine, or who are intolerant to or have medical contraindications for such therapies.

21 Jan 2012

Shortages of anti-infective drugs can put patients at risk and alter clinical care

Shortages of key drugs used to fight infections represent a public health emergency and can put patients at risk, according to a review published in Clinical Infectious Diseases and available online.

20 Jan 2012

Alpha-hemolysin may play an unexpected role in UTIs

Researchers from the University of Utah have identified a process by which the most common types of urinary tract infection-causing bacteria are able to trigger bladder cell shedding and disable immune responses. According to this new study, published in the Jan. 19, 2012, issue of Cell Host & Microbe, α-hemolysin, a toxin secreted by many strains of Escherichia coli (E. coli), may play an important, unexpected role during both the establishment and persistence of urinary tract infections.

19 Jan 2012

New Yorker mistakenly billed for $44.8 million from hospital

Unemployed doorman Alexis Rodriguez says he almost became ill when he received a $44.8 million bill from the Bronx-Lebanon Hospital Center. Rodriguez was hospitalized last spring with pneumonia and was afraid the bill was legitimate. His actual bill stood at $300.

17 Jan 2012

Pneumonia News and Research

Latest Pneumonia News and Research

Breakthrough discovery about Rhizobium radiobacter

FDA clears Meridian Bioscience's TRU Legionella test

USPTO issues two patents on 'Novel Shigella protein antigens and methods' to IVI

WHO urging Afghans to vaccinate children for measles following outbreak in western region

Pfizer responds to CDC’S ACIP discussion related to use of Prevnar 13 in adults over 50

Enrollment complete in Onyx Phase 3 ASPIRE trial for relapsed multiple myeloma

Intramuscular midazolam effective in treating status epilepticus

Compound makes imipenem 16 times more effective against antibiotic-resistant K. pneumoniae

Grand Challenges Canada, Gates Foundation announce grants for innovative Global Health projects

Grand Challenges Canada announces 15 grants to support rising stars in global health

Asian bird flu update for Ferbruary 2012

New MRSA ‘superbug’ worries experts

Potential way to block second wave of death from pneumonia treatment

Certain strains of P. aeruginosa cause WBCs to produce high levels of histamine

Study investigates how bacteria change their disguise to evade vaccines

New study aims to prevent bacterial infections in sub-Saharan African kids

EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC

Shortages of anti-infective drugs can put patients at risk and alter clinical care

Alpha-hemolysin may play an unexpected role in UTIs

New Yorker mistakenly billed for $44.8 million from hospital

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Pneumonia News and Research

Latest Pneumonia News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in